| Recruiting | Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982 | Essen Biotech | Phase 1 / Phase 2 |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Completed | Pomalidomide for Kaposi Sarcoma in People With or Without HIV NCT01495598 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults W NCT00923936 | National Cancer Institute (NCI) | Phase 2 |
| Completed | KSHV Infection in Blood Donors From Texas NCT00006310 | The University of Texas Health Science Center at San Antonio | — |
| Completed | Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton NCT00002189 | Baker Norton Pharmaceuticals | Phase 2 |
| Unknown | A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Relat NCT00002318 | Sequus Pharmaceuticals | Phase 3 |
| Completed | A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneo NCT00002185 | Agouron Pharmaceuticals | Phase 2 |
| Completed | Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi NCT00000807 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma NCT00000660 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment o NCT00000725 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. NCT00002167 | Clinical Solutions | Phase 2 |
| Completed | A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/V NCT00002093 | Nexstar Pharmaceuticals | Phase 3 |
| Completed | A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma NCT00000763 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associ NCT00000687 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma NCT00000954 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma NCT00002131 | Otsuka America Pharmaceutical | Phase 2 |
| Completed | A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS NCT00000987 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patient NCT00000695 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma NCT00000996 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatm NCT00001059 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, NCT00000681 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma NCT00002188 | Anderson Clinical Research | Phase 2 |
| Completed | Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi NCT00002147 | Sequus Pharmaceuticals | Phase 3 |
| Completed | The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma NCT00001114 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma NCT00002439 | Anderson Clinical Research | N/A |
| Completed | SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment NCT00005931 | SUGEN | Phase 2 |
| Completed | A Study of Tecogalan Sodium NCT00002342 | Daiichi Pharmaceuticals | Phase 1 |
| Completed | A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous NCT00002262 | University of California, San Francisco | Phase 1 |
| Completed | The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma NCT00002366 | Abbott | Phase 2 |
| Completed | Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma NCT00002259 | Lederle Laboratories | Phase 2 |
| Completed | A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days NCT00002136 | Daiichi Pharmaceuticals | Phase 1 |
| Completed | Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients NCT00002445 | Cytran | Phase 3 |
| Completed | A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma NCT00002212 | Ligand Pharmaceuticals | Phase 2 |
| Completed | A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant NCT00000694 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 NCT00002137 | Daiichi Pharmaceuticals | Phase 1 |
| Completed | A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma NCT00002319 | Sequus Pharmaceuticals | Phase 3 |
| Completed | A Study of Patients With AIDS Syndrome NCT00001120 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Mali NCT00002153 | DEKK-TEC, Inc. | Phase 1 |
| Completed | A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma NCT00000769 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma NCT00002314 | Hoffmann-La Roche | Phase 2 |
| Completed | A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. NCT00002138 | Daiichi Pharmaceuticals | Phase 1 |
| Completed | A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma NCT00001113 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vin NCT00002105 | Sequus Pharmaceuticals | Phase 3 |
| Completed | Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma NCT00002226 | SUGEN | N/A |
| Completed | A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malign NCT00051597 | Seagen Inc. | Phase 1 / Phase 2 |